Search

Search Results

• Chemotherapy and alternative therapies for malignant pleural mesothelioma

  S. Crivellari, F. Ugo, N. Trincheri, A. Roveta, L. Randi, R. Libener, G. Ferretti, D. Degiovanni, S. Zai, F. Grosso

  15-06-2015

  https://doi.org/10.4081/wpph.2015.6700

  871

  PDF: 1780

• Giant cell tumour of bone: a case report

  F. Grosso, S. Crivellari, N.F. Trincheri, F. Ugo, M.G. Candeo, A. Pertino, S. Zai, A. Aurelio, N. Mariani, M. Mancuso

  15-06-2015

  https://doi.org/10.4081/wpph.2015.6705

  825

  PDF: 4544

• Pleural sarcomatoid mesothelioma: clinical-pathological and survival analysis of a series of 80 cases, multicentre retrospective study

  G. Gallizzi, S. Crivellari, A. Roveta, A. Muzio, S. Zai, G. Taverna, A. Aurelio, R. Libener, N. Mariani, M. D’Angelo, D. Degiovanni, F. Grosso

  15-06-2015

  https://doi.org/10.4081/wpph.2015.6707

  827

  PDF: 8733

• Malignant pleural mesothelioma: review and analysis of clinical studies presented at ASCO 2015

  F. Grosso, S. Crivellari, G. Gallizzi, N.F. Trincheri, S. Zai, D. Degiovanni

  15-06-2015

  https://doi.org/10.4081/wpph.2015.6716

  776

  PDF: 1030

• Attività di sunitinib in un caso di carcinoma renale dei dotti di Bellini

  S. Zai, P. Guglielmini, P.L. Piovano, R. Cevoli, A. Aurelio, F. Grosso

  15-06-2013

  https://doi.org/10.4081/wpph.2013.6749

  632

  PDF: 804

• Role of radiotherapy in the treatment of malignant pleural mesothelioma

  P. Franzone, F. Grosso, L. Todisco, L. Berretta, S. Zai, A. Aurelio, G. Pozzi, A. Orecchia, M. Mancuso, F. Musante, G. Ferretti

  15-06-2014

  https://doi.org/10.4081/wpph.2014.6737

  1114

  PDF: 1355
• 

  Post-COVID oncology

  M. Rossi, G. Bellotti, F. Blengio, V. Fusco, P. Guglielmini, R. Manfredi, P. Piovano, E. Traverso, M. Vincenti, S. Zai, A. Pertino, M. Alessio, I. De Martino, G. Piacentini, A. Ghiglione, E. Ferrero

  30-06-2020

  https://doi.org/10.4081/wpph.2020.9245

  474

  PDF: 310
• 

  Malignant pleural mesothelioma in the elderly patient. Retrospective study in the centers of Alessandria and Casale Monferrato

  F. Grosso, A. Kasa, G. Gallizzi, S. Crivellari, D. Degiovanni, E. Ponte, S. Zai

  15-06-2016

  https://doi.org/10.4081/wpph.2016.6947

  1455

  PDF: 8475

• Second-line treatment with Axitinib: an effective and well-tolerated weapon in the therapeutic sequence of clear cell renal cell carcinoma

  P. Guglielmini, A. Serao, S. Zai, P.L. Piovano, F. Grosso

  15-06-2015

  https://doi.org/10.4081/wpph.2015.6697

  626

  PDF: 627